FDA Inspection 1256410 — Soulaire Corporation

Soulaire Corporation — FEI 3031814196

The FDA completed an inspection of Soulaire Corporation on Dec 5, 2024 in Santa Monica, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Dec 5, 2024
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Santa Monica, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.